perylene has been researched along with Diabetes Mellitus, Type 2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, Y; Hao, F; Huang, Y; Li, Y; Liang, C; Liu, L; Qiu, Y; Song, Z; Sun, L; Sun, Y; Wang, G; Wang, S; Wu, Y; Yang, S; Yang, X; Yao, X; Yi, J; Yu, C; Zheng, L | 1 |
| Huang, M; Ma, X; Xiong, M; Xu, C; Yang, J; Yang, X; Zhang, TC; Zhao, P; Zheng, S; Zhou, Q | 1 |
2 other study(ies) available for perylene and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Hypericin maintians PDX1 expression via the Erk pathway and protects islet β-cells against glucotoxicity and lipotoxicity.
Topics: Animals; Anthracenes; Antioxidants; Apoptosis; Cell Line; Cell Survival; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Fatty Acids; Glucose; Homeodomain Proteins; Insulin-Secreting Cells; Insulinoma; Lipids; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Nitric Oxide; Perylene; Rats; Trans-Activators | 2019 |
Antidiabetic activity of perylenequinonoid-rich extract from Shiraia bambusicola in KK-Ay mice with spontaneous type 2 diabetes mellitus.
Topics: Acetates; Acetyl-CoA Carboxylase; AMP-Activated Protein Kinases; Animals; Ascomycota; Biomarkers; Blood Glucose; Blotting, Western; Cell Line; Chromatography, Liquid; Diabetes Mellitus, Type 2; Disease Models, Animal; Dose-Response Relationship, Drug; Glucose Transporter Type 4; Hypoglycemic Agents; Insulin; Insulin Resistance; Lethal Dose 50; Lipids; Male; Myoblasts, Skeletal; Perylene; Phosphorylation; Protein Transport; Rats; Sasa; Signal Transduction; Solvents; Spectrometry, Mass, Electrospray Ionization; Time Factors | 2016 |